Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Pashayan

Showing results (101-110 of 180) with videos related to

Pageof 18
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 4, 2022
Polygenic risk scores and risk-stratified breast cancer screening: Familiarity and perspectives of health care professionalsJulie Lapointe, Anne-Catherine Buron, Cynthia Mbuya-Bienge, et al.
BMJ Open|May 2, 2025
Primary care providers' experience and satisfaction with personalised breast cancer screening risk communication: a descriptive cross-sectional studyArian Omeranovic, Julie Lapointe, Philippe Fortier, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 22, 2024
Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensusThomas A Harding, Richard M Martin, Samuel Wd Merriel, et al.
European Urology Focus|April 8, 2023
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate LesionsVasilis Stavrinides, Ece Eksi, Ron Finn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2016
Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next StepsPamela M Marcus, Nora Pashayan, Timothy R Church, et al.
Journal of Personalized Medicine|February 5, 2021
Women's Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in CanadaCynthia Mbuya Bienge, Nora Pashayan, Jennifer D Brooks, et al.
Nature Communications|February 2, 2022
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samplesJames E Barrett, Chiara Herzog, Allison Jones, et al.
Nature Reviews. Clinical Oncology|February 28, 2018
Epigenome-based cancer risk prediction: rationale, opportunities and challengesMartin Widschwendter, Allison Jones, Iona Evans, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
Genome Medicine|July 19, 2022
Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy womenThomas E Bartlett, Iona Evans, Allison Jones, et al.
Pageof 18

Showing results (101-110 of 180) with videos related to

Sort By:
Pageof 18
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 4, 2022
Polygenic risk scores and risk-stratified breast cancer screening: Familiarity and perspectives of health care professionalsJulie Lapointe, Anne-Catherine Buron, Cynthia Mbuya-Bienge, et al.
BMJ Open|May 2, 2025
Primary care providers' experience and satisfaction with personalised breast cancer screening risk communication: a descriptive cross-sectional studyArian Omeranovic, Julie Lapointe, Philippe Fortier, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 22, 2024
Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensusThomas A Harding, Richard M Martin, Samuel Wd Merriel, et al.
European Urology Focus|April 8, 2023
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate LesionsVasilis Stavrinides, Ece Eksi, Ron Finn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2016
Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next StepsPamela M Marcus, Nora Pashayan, Timothy R Church, et al.
Journal of Personalized Medicine|February 5, 2021
Women's Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in CanadaCynthia Mbuya Bienge, Nora Pashayan, Jennifer D Brooks, et al.
Nature Communications|February 2, 2022
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samplesJames E Barrett, Chiara Herzog, Allison Jones, et al.
Nature Reviews. Clinical Oncology|February 28, 2018
Epigenome-based cancer risk prediction: rationale, opportunities and challengesMartin Widschwendter, Allison Jones, Iona Evans, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in CanadaMeghan J Walker, Anna Neely, Antonis C Antoniou, et al.
Genome Medicine|July 19, 2022
Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy womenThomas E Bartlett, Iona Evans, Allison Jones, et al.
Pageof 18